Zusammenfassung
Eine Entzündung pulmonaler Gefäße erfolgt meist auf dem Boden systemischer Vaskulitiden. Im Folgenden sollen diese neben den selteneren auf die Lunge beschränkten Vaskulitiden dargestellt werden. Gelegentlich kann es auch im Rahmen von Kollagenosen bzw.bei der rheumatoiden Arthritis im Rahmen einer generalisierten Rheumavaskulitis zu einer pulmonalen Angiitis kommen (s. Abschn. 25.2).
Chapter PDF
Literatur
Asherson RA, Cervera R (1995) Review: antiphospholipid antibodies and the lung. J Rheumatol 22/1: 62–66.
Asherson RA, Cervera R, Piette JC et al. (1998) Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine 77/3: 195–207.
Austin HA, Klippel JH, Balow JE, le Riche NG, Sternberg AD, Plotz PH, Decker, JL (1986) Therapy of lupus nephritis. Controlled trial of prednisone an cytotoxic drugs. N Engl J Med 314/10: 614–619.
Baydur A, Mongan ES (1988) Thoracic manifestations in rheumatoid arthritis. Sem Respir Med 9: 305–317.
Bouros D, Nicholson AC, Polychronopoulos V, du Bois RM (2000) Acute interstitial pneumonia. Eur Respir J 15: 412–418.
Cannon GW, Zimmermann GA (eds) (1990) The lung in rheumatic diseases. Dekker, New York, Basel.
Caplan A (1953) Certain radiological appearances in the chest of coal miners suffering from rheumatoid arthritis. Thorax 8: 29–37.
Crausman RS, Achenbach GA, Pluss WT, O’Brien RF, Jennings CA (1995) Pulmonary capillaritis and alveolar hemorrhage associated with the antiphospholipid antibody syndrome. J Rheumatol 22/3: 554–556.
Crausman RS, Jennings CA, Tuder RM, Ackerson LM, Irvin CG, King TE Jr (1996) Pulmonary histiocytosis X: pulmonary function and exercise pathophysiology. Am J Respir Crit Care Med 153/1: 426–435.
Constantopoulos SH, Papadimitriou CS, Moutsopoulos HM (1985) Respiratory manifestations in primary Sjögren’s syndrome: a clinical, functional, and histologic study. Chest 83: 226–229.
Dickey BF, Myers AR (1984) Pulmonary disease in polymyositis/ dermatomyositis. Semin Arthritis Rheum 14: 60–76.
Erkan F (1999) Pulmonary involvement in Behçet disease. Current Opinion in Pulmonary Medicine. 5/5: 314–318.
Fauci AS, Barton H, Katz P, Wolff S (1983) Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 98: 76–85.
Geddes DM, Corrin B, Brewerton DA (1977) Progressive airway obliteration in adults and its associations with rheumatoid. QJ Med 184: 427–444.
Genth E, Kaufmann S, Mierau R (1993) Das Anti-(Aminoacyl-tRNA-)Synthetase-Syndrom (Jo-1-Syndrom). Akt Rheumatol 18: 113–119.
Gross WL (1999a) Primär systemische Vaskulitiden.Teil I: Allgemeine Übersicht. Internist 40/7: 779–794.
Gross WL (1999b) Primär systemische Vaskulitiden.Teil II: Krankheitsbilder. Internist 40/9: 951–968.
Gross WL (1999c) Primär systemische Vaskulitiden.Teil III: Pathogenese und Therapie. Internist. 40/11: 1194–1215.
Gross WL (1999d) New concepts in treatment protocols for severe systemic vasculitis. Current Opinion in Rheumatology. 11/1: 41–46.
Guzman LR, Gall EP, Pitt M, Lull G (1978) Psoriatic spondylitis: association with advanced nongranulomatous upper lobe pulmonary fibrosis. JAMA 239: 1416–1417.
Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth-Young CG, Loizou S, Hughes GR (1983) Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 2/8361: 1211–1214.
Harris N (1994) Antiphospholipid syndrome. In: Klippel JH, Diepper PA (eds) Rheumatology. Mosby, St. Louis Baltimore Boston.
Hunninghake GW, Fauci AS (1979) Pulmonary involvement in the collagen vascular diseases. Am Rev Respir Dis 119: 471–503.
International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335/8697: 1078–1080.
Jenette JC, Falk RJ (1997) Small-vessel vasculitis. N Engl. J Med 337: 1512–1523.
Jenette JC, Falk RJ, Andrassy K et al. (1994) Chapel Hill: Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37/2: 187–192.
Lamprecht P, Gause A, Gross WL (1999) Cryoglobulinemic vasculitis. Arthritis Rheum 42/12: 2507–2516.
Langford CA, Sneller MC, Hallahan CW et al. (1996) Clinical features and therapeutic management of subglottic stenosis in patients with Wegener’s granulomatosis. Arthritis Rheum 39/10: 1754–1760.
Leavitt RY, Fauci AS, Bloch DA et al. (1990) The American College of Rheumatology 1990 criteria for the classification of Wegeners granulomatosis. Arthritis Rheum 33: 1101–1107.
Mahadeva R, Walsh G, Flower CDR, Shneerson JM (2000) Clinical and radiological characteristics of lung disease in inflammatory bowel disease. Eur Respir J 15: 41–48.
Nugent AM, Elliott H, McGuigan JA, Varghese G (1996) Pulmonary amyloidosis: treatment with laser therapy and systemic steroids. Repiration Medicine 90: 433–435.
Perez T, Remy Jardin M, Cortet B (1998) Airways involvement in rheumatoid arthritis. Am J Respir Crit Care Med 157: 1658–1665.
Pines A, Kaplinsky N, Olchovsky D, Rozenman J, Frankl O (1985) Pleuropulmonary manifestations of systemic lupus erythematosus: clinical features of its subgroups. Prognostic and therapeutic implications. Rev Chest 88: 129–135.
Prakash UBS, Luthra HS, Divertie MB (1985) Intrathoracic manifestations in mixed connective tissue disease. Mayo Clin Proc 60: 813–821.
Reuter M, Schnabel A, Wesner F, Tetzlaff K, Risheng Y, Gross WL, Heller M (1998) Pulmonary Wegener’s granulomatosis: correlation between high-resolution CT findings and clinical scoring of disease activity. Chest 114/2: 500–506.
Rosenow EC, Strimlan CV, Muhm JR et al. (1977) Pleuropulmonary manifestations of ankylosing spondylitis. May Clin Proc 52: 641.
Röther E, Kempis J von, Peter HH (1999) Rheumazentrum Südbaden: Kriterien zur Diagnose oder Klassifikation rheumatischer Erkrankungen, 3. Aufl.
Sakane S, Mitsuhiro T, Suzuki N, Inaba G (1999) Behçet’s Disease. N Engl J Med 341/17: 1284–1291.
Salmeron G, Greenberg SD, Lidsky MD (1981) Polymyositis and diffuse interstitial lung disease. A review of the pulmonary histopathologic findings. Arch Intern Med 141: 1005–1010.
Schnabel A, Reuter M, Csernok E, Richter C, Gross WL (1999) Subclinical alveolar bleeding in pulmonary vasculitides: correlation with indices of disease activity. Eur Respir J 14/1: 118–124.
Segal R, Caspi D, Tisher M et al. (1988) Accelerated nodulosis and vasculitis during methotrexate therapy for RA. Arthritis Rheum 31: 1182–1185.
Silberstein SL, Barland P, Grayzel AL (1980) Pulmonary dysfunction in systemic lupus erythematosus: prevalence, classification and correlation with other organ involvement. J Rheumatol 7: 187–195.
Skinner M, Anderson JJ,. Simmon SR et al. (1996) Treatment of 100 patients with primary amyloidosis: a randomized trial of me-phalan, prednisone, and colchicine alone. Am J Med 100: 290–298.
Sullivan WD, Hurst DM, Harmon CE (1984) A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine 63: 92–107.
Stupi AM, Steen VD, Owens GR, Barnes EL, Rodnan GP, Medsger TA jr (1986) Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum 29: 515–524.
Yoshida S, Akizuki M, Mimori T, Yamagara H, Inada S, Homma M (1983) The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue disease. A marker for a subset of polymyositis with interstitial pulmonary fibrosis. Arthritis Rheum 26: 604–611.
Yousem SA, Colby TV, Carrington CB (1985) Lung biopsy in rheumatoid arthritis. Am Rev Respir Dis 131: 770–777.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Prasse, A., Costabel, U. (2002). Interstitielle Lungenerkrankungen bei Systemerkrankungen. In: Matthys, H., Seeger, W. (eds) Klinische Pneumologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-08120-4_25
Download citation
DOI: https://doi.org/10.1007/978-3-662-08120-4_25
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-08121-1
Online ISBN: 978-3-662-08120-4
eBook Packages: Springer Book Archive